Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2010, Article ID 517178, 3 pages
http://dx.doi.org/10.1155/2010/517178
Case Report

X-Linked Lymphoproliferative Disease Presenting as Pancytopenia in a 10-Month-Old Boy

Departments of Pediatrics and Internal Medicine, University of South Carolina School of Medicine, 14 Medical Park Suite 400, Columbia, SC 29203, USA

Received 10 February 2010; Accepted 14 April 2010

Academic Editor: Abhay R. Satoskar

Copyright © 2010 S. Nicole Chadha and David Amrol. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Horne, G. Janka, and G. Janka, “Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis,” British Journal of Haematology, vol. 129, no. 5, pp. 622–630, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. D. Howie, J. Sayos, C. Terhorst, and M. Morra, “The gene defective in X-linked lymphoproliferative disease controls T cell dependent immune surveillance against Epstein-Barr virus,” Current Opinion in Immunology, vol. 12, no. 4, pp. 474–478, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. P. L. Schwartzberg, K. L. Mueller, H. Qi, and J. L. Cannons, “SLAM receptors and SAP influence lymphocyte interactions, development and function,” Nature Reviews Immunology, vol. 9, no. 1, pp. 39–46, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. P. Engel, M. J. Eck, and C. Terhorst, “The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease,” Nature Reviews Immunology, vol. 3, no. 10, pp. 813–821, 2003. View at Google Scholar · View at Scopus
  5. A. J. MacGinnitie and R. Geha, “X-linked lymphoproliferative disease: genetic lesions and clinical consequences,” Current Allergy and Asthma Reports, vol. 2, no. 5, pp. 361–367, 2002. View at Google Scholar · View at Scopus
  6. M. Morra, D. Howie, and D. Howie, “X-linked lymphoproliferative disease: a progressive immunodeficiency,” Annual Review of Immunology, vol. 19, pp. 657–682, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. S. Latour and A. Veillette, “Molecular and immunological basis of X-linked lymphoproliferative disease,” Immunological Reviews, vol. 192, pp. 212–224, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Henter, G. Elinder, and A. Ost, “Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society,” Seminars in Oncology, vol. 18, no. 1, pp. 29–33, 1991. View at Google Scholar
  9. R. S. Geha, L. D. Notarangelo, and L. D. Notarangelo, “Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee,” The Journal of Allergy and Clinical Immunology, vol. 120, no. 4, pp. 776–794, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Griscelli, A. Durandy, and D. Guy-Grand, “A syndrome associating partial albinism and immunodeficiency,” American Journal of Medicine, vol. 65, no. 4, pp. 691–702, 1978. View at Google Scholar · View at Scopus
  11. J. Kaplan, I. De Domenico, and D. M. Ward, “Chediak-Higashi syndrome,” Current Opinion in Hematology, vol. 15, no. 1, pp. 22–29, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. M. C. Milone, D. E. Tsai, R. L. Hodinka, L. B. Silverman, A. Malbran, M. A. Wasik, and K. E. Nichols, “Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy,” Blood, vol. 105, no. 3, pp. 994–996, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus